Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 301292, 15 pages
http://dx.doi.org/10.1155/2015/301292
Research Article

Prokineticin 2 Upregulation in the Peripheral Nervous System Has a Major Role in Triggering and Maintaining Neuropathic Pain in the Chronic Constriction Injury Model

1Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, 00185 Rome, Italy
2Confocal Microscopy Unit, European Brain Research Institute (EBRI) “Rita Levi-Montalcini”, 00143 Rome, Italy
3Department of Pharmacological and Biomolecular Sciences, University of Milan, 20129 Milan, Italy
4Unit of Human Anatomy, Department of Biomedical Sciences and Biotechnologies, University of Brescia, 25123 Brescia, Italy
5Department of Life and Environment Sciences, University of Cagliari, 09124 Cagliari, Italy
6Department of Chemical and Pharmaceutical Sciences, University of Ferrara, 44-100 Ferrara, Italy

Received 11 June 2014; Accepted 3 October 2014

Academic Editor: Livio Luongo

Copyright © 2015 Roberta Lattanzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Abbadie, “Chemokines, chemokine receptors and pain,” Trends in Immunology, vol. 26, no. 10, pp. 529–534, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. L. Negri and R. Lattanzi, “Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system,” Current Opinion in Pharmacology, vol. 12, no. 1, pp. 62–66, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. E. Giannini, R. Lattanzi, A. Nicotra et al., “The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14646–14651, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. LeCouter, C. Zlot, M. Tejada, F. Peale, and N. Ferrara, “Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 48, pp. 16813–16818, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Dorsch, Y. Qiu, D. Soler et al., “PK1/EG-VEGF induces monocyte differentiation and activation,” Journal of Leukocyte Biology, vol. 78, no. 2, pp. 426–434, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Franchi, E. Giannini, D. Lattuada et al., “The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1,” BMC Immunology, vol. 9, article 60, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. Martucci, S. Franchi, E. Giannini et al., “Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages,” British Journal of Pharmacology, vol. 147, no. 2, pp. 225–234, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. G. Moalem and D. J. Tracey, “Immune and inflammatory mechanisms in neuropathic pain,” Brain Research Reviews, vol. 51, no. 2, pp. 240–264, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. L. Negri, R. Lattanzi, E. Giannini, and P. Melchiorri, “Modulators of Pain: Bv8 and prokineticins,” Current Neuropharmacology, vol. 4, no. 3, pp. 207–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Y. Cheng, F. M. Leslie, and Q.-Y. Zhou, “Expression of prokineticins and their receptors in the adult mouse brain,” Journal of Comparative Neurology, vol. 498, no. 6, pp. 796–809, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. W.-P. Hu, C. Zhang, J.-D. Li et al., “Impaired pain sensation in mice lacking prokineticin 2,” Molecular Pain, vol. 2, article 35, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. Negri, R. Lattanzi, E. Giannini, and P. Melchiorri, “Bv8/Prokineticin proteins and their receptors,” Life Sciences, vol. 81, no. 14, pp. 1103–1116, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. Vellani, M. Colucci, R. Lattanzi et al., “Sensitization of transient receptor potential vanilloid 1 by the prokineticin receptor agonist Bv8,” The Journal of Neuroscience, vol. 26, no. 19, pp. 5109–5116, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. de Felice, P. Melchiorri, M. H. Ossipov, T. W. Vanderah, F. Porreca, and L. Negri, “Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression,” Neuroscience Letters, vol. 521, no. 1, pp. 40–45, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. Lattanzi, C. Congiu, V. Onnis et al., “Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization,” International Journal of Pharmaceutical Sciences and Research. In press.
  16. D. Maftei, V. Marconi, F. Florenzano et al., “Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar · View at PubMed
  17. G. J. Bennett and Y.-K. Xie, “A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man,” Pain, vol. 33, no. 1, pp. 87–107, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. Griffin and W. J. Thompson, “Biology and pathology of nonmyelinating schwann cells,” Glia, vol. 56, no. 14, pp. 1518–1531, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. N. Lawson, A. A. Harper, E. I. Harper, J. A. Garson, and B. H. Anderton, “A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones,” Journal of Comparative Neurology, vol. 228, no. 2, pp. 263–272, 1984. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. L. Negri, R. Lattanzi, E. Giannini et al., “Nociceptive sensitization by the secretory protein Bv8,” British Journal of Pharmacology, vol. 137, no. 8, pp. 1147–1154, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. L. Negri, R. Lattanzi, E. Giannini et al., “Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior,” The Journal of Neuroscience, vol. 26, no. 25, pp. 6716–6727, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. K. Weller, P. W. Reeh, and S. K. Sauer, “TRPV1, TRPA1, and CB1 in the isolated vagus nerve—axonal chemosensitivity and control of neuropeptide release,” Neuropeptides, vol. 45, no. 6, pp. 391–400, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. Sommer and M. Kress, “Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia,” Neuroscience Letters, vol. 361, no. 1–3, pp. 184–187, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. Sacerdote, S. Franchi, S. Moretti et al., “Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain,” Journal of Neuroimmune Pharmacology, vol. 8, no. 1, pp. 202–211, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. Rotshenker, “Wallerian degeneration: the innate-immune response to traumatic nerve injury,” Journal of Neuroinflammation, vol. 8, article 109, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. C. Kleinschnitz, H. H. Hofstetter, S. G. Meuth, S. Braeuninger, C. Sommer, and G. Stoll, “T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression,” Experimental Neurology, vol. 200, no. 2, pp. 480–485, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. N. Noma, J. Khan, I.-F. Chen et al., “Interleukin-17 levels in rat models of nerve damage and neuropathic pain,” Neuroscience Letters, vol. 493, no. 3, pp. 86–91, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Martucci, A. E. Trovato, B. Costa et al., “The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice,” Pain, vol. 137, no. 1, pp. 81–95, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. L. Kojundzic, I. Dujmovic, I. Grkovic, and D. Sapunar, “Regional differences in epidermal thickness and behavioral response following partial denervation of the rat paw,” International Journal of Neuroscience, vol. 118, no. 12, pp. 1748–1762, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. J. C. Peleshok and A. Ribeiro-da-Silva, “Delayed reinnervation by nonpeptidergic nociceptive afferents of the glabrous skin of the rat hindpaw in a neuropathic pain model,” Journal of Comparative Neurology, vol. 519, no. 1, pp. 49–63, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. Beggs, X. J. Liu, C. Kwan, and M. W. Salter, “Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier,” Molecular Pain, vol. 6, article 74, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. C. Guilini, K. Urayama, G. Turkeri et al., “Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 298, no. 3, pp. H844–H852, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. F. Shojaei, X. Wu, C. Zhong et al., “Bv8 regulates myeloid-cell-dependent tumour angiogenesis,” Nature, vol. 450, no. 7171, pp. 825–831, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. X. Qu, G. Zhuang, L. Yu, G. Meng, and N. Ferrara, “Induction of Bv8 Expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: Key role of Stat3 signaling,” Journal of Biological Chemistry, vol. 287, no. 23, pp. 19574–19584, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. B. Yan, J.-J. Wei, Y. Yuan et al., “IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation,” The Journal of Immunology, vol. 190, no. 11, pp. 5882–5893, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. H. Xin, R. Lu, H. Lee et al., “G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells,” The Journal of Biological Chemistry, vol. 288, no. 19, pp. 13842–13849, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Schweizerhof, S. Stösser, M. Kurejova et al., “Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain,” Nature Medicine, vol. 15, no. 7, pp. 802–807, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Tsuda, Y. Kohro, T. Yano et al., “JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats,” Brain, vol. 134, no. 4, pp. 1127–1139, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. S. Stösser, M. Schweizerhof, and R. Kuner, “Hematopoietic colony-stimulating factors: new players in tumor-nerve interactions,” Journal of Molecular Medicine, vol. 89, no. 4, pp. 321–329, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. C. E. Egwuagu, “STAT3 in CD4+ T helper cell differentiation and inflammatory diseases,” Cytokine, vol. 47, no. 3, pp. 149–156, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. S. Chung, X. Wu, G. Zhuang et al., “An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy,” Nature Medicine, vol. 19, no. 9, pp. 1114–1123, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus